Lead Global Immuno-Oncology, Cell Therapy, and Precision Medicine Portfolio: - Partner Globally: Build and Lead Highly Engaged Global Teams of Dedicated Experts - Optimize Development: Delivering Innovative and Accessible Treatments to Patients Faster - Define and Execute Strategy: Maximize Benefit to Patients and Ensure Shareholder Value

Head of Chimeric Antigen Receptor T-Cell (CART) Program Management Office | Immunotherapy | Cell and Gene Therapy Unit. KYMRIAH- Partnered with a dedicated team of professionals committed to bringing hope to cancer patients and their families: We never give up because patients are counting on us. - Created a culture of transparency, collaboration, and communication in order to accelerate the delivery of new products: One Team Working Together. - Challenged standard practice to drive innovative thinking: Do what it takes to get the product in patient's hands without comprising safety or integrity.- Removed organizational obstacles: Built an environment where teams had the freedom to operate and focus on what is most important - our patients.

• Seamless Integration: Strategy and Operations for Global Oncology / Hematology and Sickle Cell Disease• Passionate Delivery: JADENU submissions & approvals delivered ahead of schedule. Anti-p selectin for Sickle Cell Disease: ADAKVEO• Professional Leadership: Program Management Function Head for 14 US-Based Staff. EXJADE®, JADENU®, ADAKVEO®

Senior Vice President, Development• Created culture where team members took personal ownership of the organization’s success• Aligned decision processes to ensure all assets had the resources to deliver our aggressive objectives• Led governance to address emerging issues and support programs delivering on-time and on-budget

Vice President Development, Project ManagementProject Leader, Diabetes• Led diabetes drug-device program through development and company's first NDA submission.• Integrated People/Process/Tools to improve project delivery via value-based decision making.• Partnered with Business Development staff and led due diligence teams for R&D opportunities. AFREZZA®

Worldwide Portfolio Director: CVMED (cardiovascular and metabolic disease) & Ophthalmology pipelines • Increased productivity of the cardiovascular, metabolic, and endocrine disease portfolio. • Managed global resource strategy to achieve optimal delivery of all R&D assets. • Led integration of Pharmacia portfolio into Pfizer quickly and effectively before & after acquisition. • Served as Subject Matter Expert for portfolio management discipline internally and externally. • Developed Processes, Tools, and Behaviors necessary to drive portfolio centered decisions.

Global Project Leader, Diabetes and Ophthalmology:• Led global development teams in Diabetes (inhaled insulin) and Ophthalmology.(VEGF inhibitor)• Led global alliance teams and R&D due diligence assessment and asset integration teams.• Awarded Research & Development "Project Team of the Year".• EXUBERA®, MACUGEN®

Chef de Projet / Global Project Leader, Vaccines:• Led vaccine development programs for global markets: Meningitis, Avian Flu, Rabies• Served as Alliance Leader for small EU Biotechnology companies while based in France.• Developed portfolio prioritization methodologies for strategic planning.• MENACTRA®

R&D Project Manager, Early Development:• Managed early stage drug and device product development teams: Asthma and COPD.• COMBIVENT® Unit Dose Vials, ATROVENT® HFAScientist II:• Supported early development projects via formulation development support, validation, etc.• VIRAMUNE®.